APA (7th ed.) Citation

JS, R., M, A. T., MM, V., B, F., LL, G. T., JP, E., . . . R, M. (2026). The role of the endocannabinoid system in managing neuropsychiatric symptoms in Alzheimer's disease. Frontiers in psychiatry, 16, 1709266. https://doi.org/10.3389/fpsyt.2025.1709266

Chicago Style (17th ed.) Citation

JS, Rao, Alejandra Tangarife M, Venegas MM, Forero B, González Tamayo LL, Escobar-Gallego JP, Rodríguez-Soacha DA, Ferreiros A, and Mukunda R. "The Role of the Endocannabinoid System in Managing Neuropsychiatric Symptoms in Alzheimer's Disease." Frontiers in Psychiatry 16 (2026): 1709266. https://doi.org/10.3389/fpsyt.2025.1709266.

MLA (9th ed.) Citation

JS, Rao, et al. "The Role of the Endocannabinoid System in Managing Neuropsychiatric Symptoms in Alzheimer's Disease." Frontiers in Psychiatry, vol. 16, 2026, p. 1709266, https://doi.org/10.3389/fpsyt.2025.1709266.